Metraipolis › archive › dc_8b3867de73cf
Perioperative substance P/NK1R pharmacology: from PONV control to a testable cancer neuro-immune hypothesis — Europe PMC PMID:42534550
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/42534550
- DOI
- 10.3389/fimmu.2026.1896684
- License (as archived)
- solo-consultazione
- Archived
- 2026-10-06T16:41:46.264Z
- SHA-256 of the archived text
80e02061b2f7c6a9229bfdd0ca5d94ff2022a3ea8d9f4ff4ed068e9849f79244- Stable URL of this page
https://metraipolis.com/documento/dc_8b3867de73cf
How to cite
Perioperative substance P/NK1R pharmacology: from PONV control to a testable cancer neuro-immune hypothesis — Europe PMC PMID:42534550 — Europe PMC (en), https://europepmc.org/article/MED/42534550 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_8b3867de73cf (Metraipolis archive dc_8b3867de73cf, sha256 80e02061b2f7c6a9229bfdd0ca5d94ff2022a3ea8d9f4ff4ed068e9849f79244)
BibTeX
@misc{dc8b3867de73cf,
title = {Perioperative substance P/NK1R pharmacology: from PONV control to a testable cancer neuro-immune hypothesis — Europe PMC PMID:42534550},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/42534550},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_8b3867de73cf; sha256 80e02061b2f7c6a9229bfdd0ca5d94ff2022a3ea8d9f4ff4ed068e9849f79244},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42534550. Agents can read the archived copy with the MCP tool read_document.